Craik D J, Daly N L, Waine C
Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD 4072, Australia.
Toxicon. 2001 Jan;39(1):43-60. doi: 10.1016/s0041-0101(00)00160-4.
The cystine knot structural motif is present in peptides and proteins from a variety of species, including fungi, plants, marine molluscs, insects and spiders. It comprises an embedded ring formed by two disulfide bonds and their connecting backbone segments which is threaded by a third disulfide bond. It is invariably associated with nearby beta-sheet structure and appears to be a highly efficient motif for structure stabilization. Because of this stability it makes an ideal framework for molecular engineering applications. In this review we summarize the main structural features of the cystine knot motif, focussing on toxin molecules containing either the inhibitor cystine knot or the cyclic cystine knot. Peptides containing these motifs are 26-48 residues long and include ion channel blockers, haemolytic agents, as well as molecules having antiviral and antibacterial activities. The stability of peptide toxins containing the cystine knot motif, their range of bioactivities and their unique structural scaffold can be harnessed for molecular engineering applications and in drug design. Applications of cystine knot molecules for the treatment of pain, and their potential use in antiviral and antibacterial applications are described.
胱氨酸结结构基序存在于多种物种的肽和蛋白质中,包括真菌、植物、海洋软体动物、昆虫和蜘蛛。它由两个二硫键及其连接的主链片段形成的嵌入环组成,第三个二硫键穿过该环。它总是与附近的β-折叠结构相关联,似乎是一种高效的结构稳定基序。由于这种稳定性,它成为分子工程应用的理想框架。在本综述中,我们总结了胱氨酸结基序的主要结构特征,重点关注含有抑制剂胱氨酸结或环状胱氨酸结的毒素分子。含有这些基序的肽长度为26 - 48个残基,包括离子通道阻滞剂、溶血剂以及具有抗病毒和抗菌活性的分子。含有胱氨酸结基序的肽毒素的稳定性、它们的生物活性范围以及独特的结构支架可用于分子工程应用和药物设计。本文描述了胱氨酸结分子在疼痛治疗中的应用及其在抗病毒和抗菌应用中的潜在用途。